Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Biological therapy and neurological manifestations. What do we know?
The Role of Imaging for Trigeminal Neuralgia: A Segmental Approach to High-Resolution MRI.
Factors associated with benign multiple sclerosis in the New York State MS Consortium (NYSMSC).
3K3A-activated protein C stimulates postischemic neuronal repair by human neural stem cells in mice.
Apathy in multiple sclerosis: gender matters.
miRNAs Participate in MS Pathological Processes and Its Therapeutic Response.
PRMT5-PTEN molecular pathway regulates senescence and self-renewal of primary glioblastoma neurosphere cells.
JC Virus Infects Neurons and Glial Cells in the Hippocampus.
Prognosis in multiple sclerosis and the unveiling of pathogenic clues.
Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to cognitive impairment.
Myelin-specific T helper 17 cells promote adult hippocampal neurogenesis through indirect mechanisms.
Proton MR spectroscopy with metabolite-nulling reveals elevated macromolecules in acute multiple sclerosis.
Molecular and genetic requirements for preferential recruitment of TCRBV8S2+ T cells in Lewis rat experimental autoimmune encephalomyelitis.
Changes in Serum Ceruloplasmin Levels Based on Immunomodulatory Treatments and Melatonin Supplementation in Multiple Sclerosis Patients.
Origin of oligodendrocytes in mammalian forebrains: a revised perspective.
Olfactory alterations in patients with multiple sclerosis.
Human acid sphingomyelinase structures provide insight to molecular basis of Niemann-Pick disease.
Liposomal nano-drugs based on amphipathic weak acid steroid prodrugs for treatment of inflammatory diseases.
Developmental changes in plasticity, synaptic, glia and connectivity protein levels in rat dorsal hippocampus.
Axonal activity-dependent myelination in development: Insights for myelin repair.
Antibodies against glycosylated native MOG are elevated in patients with multiple sclerosis.
Nerve conduction and electromyography studies.
Guillain-Barré syndrome.
Proteomic profile of cerebrospinal fluid in patients with multiple sclerosis using two dimensional gel electrophoresis.
Lateral and escalation therapy in relapsing-remitting multiple sclerosis: a comparative study.
Pages
« first
‹ previous
…
731
732
733
734
735
736
737
738
739
…
next ›
last »